type here...

CATEGORIES

Research Critique

LATEST

12Page 2 of 2

TRENDING

EDITORS CHOICE

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne -
Evidence that the newspaper is not sufficiently detached from promoters to provide an open-minded but skeptical perspective that readers should be able to expect.

Surprises in the Authorship of a Paper About MDMA to Treat PTSD

James Coyne -
The largest number of authors (12) are with MAPS. The for-profit corporation will manage sales for prescription MDMA when it is approved by the FDA

The Future of Cardiovascular Disease Prevention: Insights from Drs. Eric Topol and Pradeep Natarajan

Christopher Nial -
While LDL cholesterol remains a crucial target in cardiovascular prevention, it is important to look beyond this traditional marker.

Depression isn’t Caused by Low Serotonin Level, Are SSRIs still Effective?

Isabella Soerjanto MD -
Several previous studies have concluded that SSRIs can significantly reduce the risk of depression. However, a recent study refutes this.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories